Understanding shocks to welfare systems
Angie Jo’s doctoral studies find that when a collective crisis strikes, nations with shallow social safety nets, like the US, respond with massive spending.
Angie Jo’s doctoral studies find that when a collective crisis strikes, nations with shallow social safety nets, like the US, respond with massive spending.
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
By delivering an HIV vaccine candidate along with two adjuvants, researchers showed they could generate many more HIV-targeting B cells in mice.
A new book from Professor Munther Dahleh details the creation of a unique kind of transdisciplinary center, uniting many specialties through a common need for data science.
In the United States and abroad, Matthew Dolan ’81 has served as a leader in immunology and virology.
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.
Four professors and an additional alumnus honored with nation’s highest awards for scientists and engineers; Moderna, with deep MIT roots, also recognized.
Reflecting a “Moore’s Law of aviation,” commercial flight has become roughly twice as safe each decade since the 1960s; Covid-19 added a wrinkle, however.
While women and men self-reported similar vaccination rates, unvaccinated women had less intention to get vaccinated than men.
Lydia Bourouiba’s research on fluid dynamics influenced new guidance from the World Health Organization that will shape how health agencies respond to respiratory infectious diseases.
A new study finds sustained pattern changes — with a lot of regional variation.
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.
The inventor, entrepreneur, and philanthropist has co-founded and developed over 70 life-science and technology startups.
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
Associate Professor Lydia Bourouiba and artist Argha Manna take readers through a series of discoveries in infectious disease.